Now showing items 1-1 of 1

    • Cardiovascular efficacy and safety of bococizumab in high-risk patients 

      Ridker, Paul M.; Tardif, Jean Claude; Polanczyk, Carisi Anne; SPIRE Cardiovascular Outcome Investigators (2017) [Journal article]
      BACKGROUND Bococizumab is a humanized monoclonal antibody that inhibits proprotein convertase subtilisin– kexin type 9 (PCSK9) and reduces levels of low-density lipoprotein (LDL) cholesterol. We sought to evaluate the ...